NCT01694537View on ClinicalTrials.gov

The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions
Healthy
Interventions
DRUG

DLBS1033

The study drug is enteric coated DLBS1033, which contain 490 mg bioactive protein fraction.

DRUG

placebo

Placebo is made with same size and shape with study drug.

Trial Locations (1)

10430

Indonesia University, Jakarta

Sponsors

Collaborators (1)

Dexa Medica Group
All Listed Sponsors
collaborator

Dexa Medica Group

INDUSTRY

lead

Indonesia University

OTHER

NCT01694537 - The Effects of DLBS1033 on Haemostasis Parameters in Healthy Volunteers | Biotech Hunter | Biotech Hunter